017180.KS Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 apr 2024 @ 08:30):

MYUNGMOON Pharm co.,Ltd engages in the research, development, production, distribution, and sale of pharmaceuticals in South Korea and internationally...

Stats
Dagens volum	23 309.00
Gjennomsnittsvolum	66 342.00
Markedsverdi	69.40B
EPS	KRW0 ( 2023-11-14 )
Last Dividend	KRW0 ( N/A )
Next Dividend	KRW0 ( N/A )
P/E	0
ATR14	KRW2.65 (0.13%)

Volum Korrelasjon

Lang: 0.01 (neutral)

Kort: 1.00 (very strong)

Signal:(58.929) Expect same movement, but be aware

MYUNGMOON Pharm co.,Ltd Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

MYUNGMOON Pharm co.,Ltd Korrelasjon - Valuta/Råvare

0.07
( neutral )

0.08
( neutral )

0.43
( neutral )

-0.02
( neutral )

-0.15
( neutral )

0.65
( weak )

MYUNGMOON Pharm co.,Ltd Økonomi

Annual	2023
Omsetning:	KRW169.57B
Bruttogevinst:	KRW94.52B (55.74 %)
EPS:	KRW-134.35

FY	2023
Omsetning:	KRW169.57B
Bruttogevinst:	KRW94.52B (55.74 %)
EPS:	KRW-134.35

FY	2022
Omsetning:	KRW152.13B
Bruttogevinst:	KRW78.10B (51.34 %)
EPS:	KRW232.74

FY	2021
Omsetning:	KRW144.76B
Bruttogevinst:	KRW62.34B (43.06 %)
EPS:	KRW0

Financial Reports:

No articles found.

MYUNGMOON Pharm co.,Ltd

MYUNGMOON Pharm co.,Ltd engages in the research, development, production, distribution, and sale of pharmaceuticals in South Korea and internationally. It offers prescription drugs, including anti osteoarthritis, anti-inflammatory analgesics, antiphlogistic enzymes, muscle relaxant, anti rheumarthritis, antibiotics and antifungal, respiratory agents, GI therapeutics, circulation agents, anti-hypertension agents, antidiabetic drugs, narcotics, anesthetic agents, central nervous system products, female hormone products, osteoporotic therapeutics, urogentital agents, adrenocortical hormone products, oncology agents, other preparations, fillers, and anti-obesity agents for pharmacotherapy. The company also provides OTC products, such as antinausants, genitourinary system products, anti gum disease products, hepatics, parasiticides, cathartic, oral disease products, antidiarrheal agents, digestive system products, cold drugs, calcium products, nasal sprays, multiple vitamin products, eye nutrition products, eye drops, blood circulation products, circulatory solvents, skin external preparations, and topical analgesic products. In addition, it offers health supplements, quasi drugs, and blended juices. MYUNGMOON Pharm co.,Ltd was founded in 1983 and is headquartered in Seoul, South Korea.